ICU Medical, Inc. (NASDAQ:ICUI) Shares Acquired by Martingale Asset Management L P

Martingale Asset Management L P boosted its holdings in ICU Medical, Inc. (NASDAQ:ICUI) by 1,100.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 16,800 shares of the medical instruments supplier’s stock after acquiring an additional 15,400 shares during the period. Martingale Asset Management L P’s holdings in ICU Medical were worth $2,607,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently added to or reduced their stakes in the company. Harvest Fund Management Co. Ltd purchased a new stake in shares of ICU Medical in the fourth quarter valued at about $33,000. Murphy & Mullick Capital Management Corp purchased a new stake in ICU Medical in the 4th quarter valued at approximately $52,000. Venturi Wealth Management LLC grew its holdings in ICU Medical by 64.0% during the 4th quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier’s stock valued at $82,000 after buying an additional 206 shares during the last quarter. Russell Investments Group Ltd. increased its position in ICU Medical by 88.8% during the fourth quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier’s stock worth $99,000 after buying an additional 300 shares in the last quarter. Finally, Smartleaf Asset Management LLC raised its holdings in shares of ICU Medical by 166.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 907 shares of the medical instruments supplier’s stock worth $140,000 after acquiring an additional 567 shares during the last quarter. 96.10% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts recently commented on the company. StockNews.com raised ICU Medical from a “hold” rating to a “buy” rating in a research note on Friday, April 4th. Raymond James set a $97.00 price target on shares of ICU Medical in a report on Wednesday, March 12th. Finally, Needham & Company LLC reissued a “hold” rating on shares of ICU Medical in a research note on Tuesday. One analyst has rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, ICU Medical currently has an average rating of “Buy” and a consensus price target of $168.67.

ICU Medical Stock Performance

NASDAQ ICUI opened at $138.43 on Friday. The business’s 50-day moving average price is $148.66 and its 200 day moving average price is $161.17. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. ICU Medical, Inc. has a twelve month low of $93.36 and a twelve month high of $196.26. The company has a market capitalization of $3.39 billion, a PE ratio of -30.29 and a beta of 0.86.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.